Kevzara® (sarilumab) – New indication
February 28, 2023 - Regeneron and Sanofi announced the FDA approval of Kevzara (sarilumab), for treatment of adult patients with polymyalgia rheumatica who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper.
Download PDF
